[back to company universe](https://highsignal.app/case-studies)

Healthcare

# Shield Bio

Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.

sources

2

Evidence entries preserved.

affiliations

2

Andreessen Horowitz, Y Combinator

competitors

6

Mapped from High Signal graph features.

status

generated

artifact cache

last updated

2026-07-15

17:19 UTC

source evidence

Why this company exists here

## Y Combinator

yc-company-directory #1172

[official source](https://www.ycombinator.com/companies/shield-bio)

## Andreessen Horowitz

a16z-investment-list #847

[official source](https://a16z.com/investment-list/)

generated read

High Signal interpretation

Shield Bio is classified as **Healthcare** from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction

Product facets

nanopore sequencing3rd generation or "nanopore" sequencingtechnologyclinical use

mapping method

Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

## Companies similar to Shield Bio

Healthcare · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

[### Granza Bio match 57Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunitshared product terms: bio, deliver, kill, enable; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator](https://highsignal.app/case-studies/granza-bio)[### FidoCure® match 56Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners hshared extracted concept terms: sequenc; shared product terms: disease, precision, medicine, bring; shared product theme: health and clinical care; shared affiliation: Andreessen Horowitz, Y Combinator](https://highsignal.app/case-studies/fidocure)[### LEAH Labs match 54LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curativshared product terms: people, focus, clinical, us; shared product theme: health and clinical care; shared affiliation: Y Combinator](https://highsignal.app/case-studies/leah-labs)[### Call9 match 49Call9 delivers true Emergency Medicine and Palliative Care at patients'​ bedsides. Currently in Skilled Nursing Facilities, Call9 decreases the time patients wait to see an EM Physician from an average of 64 minutes to moments in emergency situations. In tandem with 24/7 onsite Clinical Care Specialists*, offsite Emergency Medicine Physicians see, diagnose and treat patients at the bedside via the Call9 proprietary platform. Our focus goes beyond the medicine to assure premium patient-centered cshared product terms: deliver, medicine, minute, clinical; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator](https://highsignal.app/case-studies/call9)[### Loop Genomics match 45Loop Genomics provides long-read sequencing solutions across a diverse set of research and clinical applications. Our platform for long-read DNA sequencing transforms short-read DNA sequencers into long-read sequencing machines.shared extracted concept terms: sequenc, clinical; shared product terms: sequenc, clinical; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator](https://highsignal.app/case-studies/loop-genomics)[### Signal Fusion match 42Signal fusion provides a multimodal analytics solution that speeds up diagnostics, personalizes treatment, and improves clinical decisions.shared extracted concept terms: clinical; shared product terms: treatment, improve, clinical; shared product theme: health and clinical care; same category: Healthcare](https://highsignal.app/case-studies/signal-fusion)

---

Canonical HTML: https://highsignal.app/case-studies/shield-bio